LGT Fund Management Co Ltd. Has $9.68 Million Stake in UnitedHealth Group Incorporated $UNH

LGT Fund Management Co Ltd. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 811.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 27,793 shares of the healthcare conglomerate’s stock after purchasing an additional 24,743 shares during the quarter. UnitedHealth Group comprises about 0.8% of LGT Fund Management Co Ltd.’s investment portfolio, making the stock its 27th largest position. LGT Fund Management Co Ltd.’s holdings in UnitedHealth Group were worth $9,680,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Norges Bank acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $3,837,207,000. Berkshire Hathaway Inc bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $1,572,193,000. Dodge & Cox raised its position in UnitedHealth Group by 117.7% in the 2nd quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock worth $2,729,912,000 after purchasing an additional 4,730,192 shares during the last quarter. Lone Pine Capital LLC acquired a new position in UnitedHealth Group during the 2nd quarter worth $528,273,000. Finally, Amundi increased its stake in shares of UnitedHealth Group by 33.8% in the 2nd quarter. Amundi now owns 6,191,871 shares of the healthcare conglomerate’s stock valued at $1,904,372,000 after buying an additional 1,565,245 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on UNH shares. Royal Bank Of Canada decreased their price target on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. Barclays reduced their target price on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Piper Sandler reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Finally, UBS Group dropped their target price on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $372.13.

Read Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $286.86 on Monday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The stock’s fifty day simple moving average is $308.28 and its 200 day simple moving average is $326.02. The company has a market capitalization of $260.38 billion, a PE ratio of 21.75, a PEG ratio of 1.32 and a beta of 0.41. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the prior year, the company earned $6.81 earnings per share. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.1%. The ex-dividend date is Monday, March 9th. UnitedHealth Group’s dividend payout ratio is 67.02%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.